GCP
TMCI icon

GSA Capital Partners’s Treace Medical Concepts TMCI Stock Holding History

GSA Capital Partners’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168K Sell
42,248
-355,759
-89% -$978K 0.01% 1568
2026
Q1 		$533K Buy
398,007
+50,252
+14% +$100K 0.03% 876
2025
Q4 		$852K Buy
347,755
+236,477
+213% +$1.03M 0.07% 454
2025
Q3 		$747K Buy
111,278
+32,336
+41% +$211K 0.06% 591
2025
Q2 		$464K Buy
78,942
+12,152
+18% +$79.2K 0.03% 970
2025
Q1 		$560K Buy
+66,790
New +$600K 0.05% 721
2024
Q4 		– Sell
-149,129
Closed -$865K – 2031
2024
Q3 		$865K Sell
149,129
-42,298
-22% -$272K 0.07% 565
2024
Q2 		$1.27M Buy
191,427
+122,154
+176% +$987K 0.09% 354
2024
Q1 		$904K Sell
69,273
-9,318
-12% -$124K 0.07% 505
2023
Q4 		$1M Buy
+78,591
New +$794K 0.08% 393

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

GSA Capital Partners's TMCI Position: Q2 2026 in Review

GSA Capital Partners reduced its Treace Medical Concepts (TMCI) stake by 89% in Q2 2026, selling an estimated $978K and leaving 42,248 shares worth $168K. The position accounts for 0.01% of the portfolio, ranked #1568.

GSA Capital Partners first reported a position in TMCI in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.27M in Q2 2024. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • GSA Capital Partners held 42,248 shares of Treace Medical Concepts worth $168K as of Q2 2026.
  • GSA Capital Partners sold 355,759 Treace Medical Concepts shares in Q2 2026, an estimated $978K.
  • Treace Medical Concepts made up 0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1568 holding.
  • GSA Capital Partners first reported a position in Treace Medical Concepts in Q4 2023 and has held it in 10 quarters since.
  • GSA Capital Partners's Treace Medical Concepts position peaked at $1.27M in Q2 2024.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.